Brian J. Druker
In 2011 Brian J. Druker was named a Thomson Reuters Citation Laureate in Medicine with Nicholas B. Lydon and Charles L. Sawyers for their development of imatinib and dasatinib, revolutionary, targeted treatments for chronic myeloid leukemia. Below are more details.
- Role: JELD-WEN Chair of Leukemia Research, and Director, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland OR USA
- Prizes & Affiliations: Howard Hughes Medical Institute Investigator